These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33412078)

  • 1. Use of medications during pregnancy and breastfeeding for Crohn's disease and ulcerative colitis.
    Laube R; Paramsothy S; Leong RW
    Expert Opin Drug Saf; 2021 Mar; 20(3):275-292. PubMed ID: 33412078
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing pharmacologic management of inflammatory bowel disease.
    Chang S; Hanauer S
    Expert Rev Clin Pharmacol; 2017 Jun; 10(6):595-607. PubMed ID: 28475384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of drugs used for the treatment of Crohn's disease.
    Pudipeddi A; Kariyawasam V; Haifer C; Baraty B; Paramsothy S; Leong RW
    Expert Opin Drug Saf; 2019 May; 18(5):357-367. PubMed ID: 31026401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating Inflammatory Bowel Disease in Pregnancy: The Issues We Face Today.
    Damas OM; Deshpande AR; Avalos DJ; Abreu MT
    J Crohns Colitis; 2015 Oct; 9(10):928-36. PubMed ID: 26129693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review.
    Gisbert JP; Chaparro M
    Drugs; 2020 Jul; 80(11):1085-1100. PubMed ID: 32562207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Table: safety of drugs for IBD in pregnancy.
    Med Lett Drugs Ther; 2018 Jul; 60(1550):e116. PubMed ID: 30036355
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitis.
    Hagan M; Cross RK
    Expert Opin Drug Saf; 2015; 14(9):1473-9. PubMed ID: 26138111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Emerging Therapies: What Are Promising in the Near Future?].
    Seo GS; Lee SH
    Korean J Gastroenterol; 2018 Feb; 71(2):81-88. PubMed ID: 29471605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis.
    McLean LP; Cross RK
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):833-42. PubMed ID: 27096357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease.
    Androulakis I; Zavos C; Christopoulos P; Mastorakos G; Gazouli M
    World J Gastroenterol; 2015 Dec; 21(47):13205-11. PubMed ID: 26715803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation.
    Schulze H; Esters P; Dignass A
    Aliment Pharmacol Ther; 2014 Nov; 40(9):991-1008. PubMed ID: 25200000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Table: safety of drugs for IBD in pregnancy.
    Med Lett Drugs Ther; 2023 Jul; 65(1680):e113. PubMed ID: 37418330
    [No Abstract]   [Full Text] [Related]  

  • 13. New drugs for the treatment of IBD during conception, pregnancy, and lactation.
    Pugliese D; Privitera G; Gisbert JP; Chaparro M
    Dig Liver Dis; 2024 Feb; 56(2):235-241. PubMed ID: 37718225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
    Matro R; Martin CF; Wolf D; Shah SA; Mahadevan U
    Gastroenterology; 2018 Sep; 155(3):696-704. PubMed ID: 29857090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proper Use of Inflammatory Bowel Disease Drugs during Pregnancy.
    Kanis SL; van der Woude CJ
    Dig Dis; 2016; 34 Suppl 1(Suppl 1):61-6. PubMed ID: 27548630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expert opinion on interleukin-12/23 and interleukin-23 antagonists as potential therapeutic options for the treatment of inflammatory bowel disease.
    Wong U; Cross RK
    Expert Opin Investig Drugs; 2019 May; 28(5):473-479. PubMed ID: 30884245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vedolizumab for ulcerative colitis and Crohn's disease: results and implications of GEMINI studies.
    Lam MC; Bressler B
    Immunotherapy; 2014; 6(9):963-71. PubMed ID: 25341118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on pregnancy and breastfeeding in the era of biologics.
    Yarur A; Kane SV
    Dig Liver Dis; 2013 Oct; 45(10):787-94. PubMed ID: 23474350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.